Brief: Natco Pharma To Buy 51.6 Mln Shares Of Adcock Ingram
23/07/2025 11:48
July 23 (Reuters) - Natco Pharma Ltd NATP.NS: TO BUY 51.6 MILLION SHARES OF ADCOCK INGRAM TOTAL INVESTMENT COST ABOUT 20 BILLION RUPEES TO INCORPORATE SUBSIDIARY IN SOUTH AFRICA WITH 21 BILLION RUPEES INVESTMENT Source text: ID:nNSE4wrn0P Further company coverage: NATP.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees